FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323543405> ?p ?o ?g. }

• W4323543405 endingPage "115493" @default.
• W4323543405 startingPage "115493" @default.
• W4323543405 abstract "The incidence and mortality rate of malignant melanoma are increasing worldwide. Metastasis reduces the efficacy of current melanoma therapies and leads to poor prognosis for patients. EZH2 is a methyltransferase that promotes the proliferation, metastasis, and drug resistance of tumor cells by regulating transcriptional activity. EZH2 inhibitors could be effective in melanoma therapies. Herein, we aimed to investigate whether the pharmacological inhibition of EZH2 by ZLD1039, a potent and selective S-adenosyl-l-methionine-EZH2 inhibitor, suppresses tumor growth and pulmonary metastasis in melanoma cells. Results showed that ZLD1039 selectively reduced H3K27 methylation in melanoma cells by inhibiting EZH2 methyltransferase activity. Additionally, ZLD1039 exerted excellent antiproliferative effects on melanoma cells in 2D and 3D culture systems. Administration of ZLD1039 (100 mg/kg) by oral gavage caused antitumor effects in the A375 subcutaneous xenograft mouse model. RNA sequencing and GSEA revealed that the ZLD1039-treated tumors exhibited changes in the gene sets enriched from the Cell Cycle and Oxidative Phosphorylation, whereas the ECM receptor interaction gene set had a negative enrichment score. Mechanistically, ZLD1039 induced G0/G1 phase arrest by upregulating p16 and p27 and inhibiting the functions of the cyclin D1/CDK6 and cyclin E/CDK2 complexes. Moreover, ZLD1039 induced apoptosis in melanoma cells via the mitochondrial reactive oxygen species apoptotic pathway, consistent with the changes in transcriptional signatures. ZLD1039 also exhibited excellent antimetastatic effects on melanoma cells in vitro and in vivo. Our data highlight that ZLD1039 may be effective against melanoma growth and pulmonary metastasis and thus could serve as a therapeutic agent for melanoma." @default.
• W4323543405 created "2023-03-09" @default.
• W4323543405 creator A5000638427 @default.
• W4323543405 creator A5044058024 @default.
• W4323543405 creator A5059665113 @default.
• W4323543405 creator A5065562045 @default.
• W4323543405 creator A5068080767 @default.
• W4323543405 creator A5081142656 @default.
• W4323543405 creator A5084000653 @default.
• W4323543405 date "2023-04-01" @default.
• W4323543405 modified "2023-09-28" @default.
• W4323543405 title "Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo" @default.
• W4323543405 cites W1965370740 @default.
• W4323543405 cites W1969485334 @default.
• W4323543405 cites W1969840060 @default.
• W4323543405 cites W1981557521 @default.
• W4323543405 cites W1985450903 @default.
• W4323543405 cites W1995275377 @default.
• W4323543405 cites W2000448910 @default.
• W4323543405 cites W2060608189 @default.
• W4323543405 cites W2082514157 @default.
• W4323543405 cites W2087243633 @default.
• W4323543405 cites W2094472651 @default.
• W4323543405 cites W2113651620 @default.
• W4323543405 cites W2121545342 @default.
• W4323543405 cites W2133770419 @default.
• W4323543405 cites W2134471382 @default.
• W4323543405 cites W2140525205 @default.
• W4323543405 cites W2149441684 @default.
• W4323543405 cites W2185464321 @default.
• W4323543405 cites W2216439242 @default.
• W4323543405 cites W2263927213 @default.
• W4323543405 cites W2264682687 @default.
• W4323543405 cites W2338736378 @default.
• W4323543405 cites W2597463662 @default.
• W4323543405 cites W2624344042 @default.
• W4323543405 cites W2802052026 @default.
• W4323543405 cites W2921128830 @default.
• W4323543405 cites W2948155539 @default.
• W4323543405 cites W2948716731 @default.
• W4323543405 cites W2970799943 @default.
• W4323543405 cites W2993953026 @default.
• W4323543405 cites W3011290602 @default.
• W4323543405 cites W3012342310 @default.
• W4323543405 cites W3041426930 @default.
• W4323543405 cites W3047740470 @default.
• W4323543405 cites W3092007298 @default.
• W4323543405 cites W3092484545 @default.
• W4323543405 cites W3094352487 @default.
• W4323543405 cites W3105919321 @default.
• W4323543405 cites W3111749809 @default.
• W4323543405 cites W3113132520 @default.
• W4323543405 cites W3126236687 @default.
• W4323543405 cites W3128646645 @default.
• W4323543405 cites W3130832757 @default.
• W4323543405 cites W3164505285 @default.
• W4323543405 cites W3174858423 @default.
• W4323543405 cites W3189658128 @default.
• W4323543405 cites W3209148700 @default.
• W4323543405 cites W3215560244 @default.
• W4323543405 cites W4200168827 @default.
• W4323543405 cites W4225262625 @default.
• W4323543405 cites W4225529913 @default.
• W4323543405 cites W4228999747 @default.
• W4323543405 cites W4284991400 @default.
• W4323543405 doi "https://doi.org/10.1016/j.bcp.2023.115493" @default.
• W4323543405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36898415" @default.
• W4323543405 hasPublicationYear "2023" @default.
• W4323543405 type Work @default.
• W4323543405 citedByCount "0" @default.
• W4323543405 crossrefType "journal-article" @default.
• W4323543405 hasAuthorship W4323543405A5000638427 @default.
• W4323543405 hasAuthorship W4323543405A5044058024 @default.
• W4323543405 hasAuthorship W4323543405A5059665113 @default.
• W4323543405 hasAuthorship W4323543405A5065562045 @default.
• W4323543405 hasAuthorship W4323543405A5068080767 @default.
• W4323543405 hasAuthorship W4323543405A5081142656 @default.
• W4323543405 hasAuthorship W4323543405A5084000653 @default.
• W4323543405 hasConcept C104317684 @default.
• W4323543405 hasConcept C121608353 @default.
• W4323543405 hasConcept C126322002 @default.
• W4323543405 hasConcept C150903083 @default.
• W4323543405 hasConcept C190283241 @default.
• W4323543405 hasConcept C199649820 @default.
• W4323543405 hasConcept C199835354 @default.
• W4323543405 hasConcept C207001950 @default.
• W4323543405 hasConcept C2777658100 @default.
• W4323543405 hasConcept C2779013556 @default.
• W4323543405 hasConcept C29537977 @default.
• W4323543405 hasConcept C33288867 @default.
• W4323543405 hasConcept C50171091 @default.
• W4323543405 hasConcept C502942594 @default.
• W4323543405 hasConcept C54355233 @default.
• W4323543405 hasConcept C55493867 @default.
• W4323543405 hasConcept C62112901 @default.
• W4323543405 hasConcept C71924100 @default.
• W4323543405 hasConcept C86803240 @default.
• W4323543405 hasConceptScore W4323543405C104317684 @default.

• next